CLINIMIX SOLUTION

Maa: Kanada

Kieli: englanti

Lähde: Health Canada

Aktiivinen ainesosa:

HISTIDINE; TRYPTOPHAN; ALANINE; DEXTROSE; METHIONINE; L-LYSINE HYDROCHLORIDE; GLYCINE; L-TYROSINE; L-PROLINE; L-ARGININE; L-VALINE; L-THREONINE; L-PHENYLALANINE; L-LEUCINE; L-ISOLEUCINE; SERINE

Saatavilla:

BAXTER CORPORATION

ATC-koodi:

B05BA10

INN (Kansainvälinen yleisnimi):

COMBINATIONS

Annos:

288MG; 108MG; 1242MG; 5G; 240MG; 348MG; 618MG; 24MG; 408MG; 690MG; 348MG; 252MG; 336MG; 438MG; 360MG; 300MG

Lääkemuoto:

SOLUTION

Koostumus:

HISTIDINE 288MG; TRYPTOPHAN 108MG; ALANINE 1242MG; DEXTROSE 5G; METHIONINE 240MG; L-LYSINE HYDROCHLORIDE 348MG; GLYCINE 618MG; L-TYROSINE 24MG; L-PROLINE 408MG; L-ARGININE 690MG; L-VALINE 348MG; L-THREONINE 252MG; L-PHENYLALANINE 336MG; L-LEUCINE 438MG; L-ISOLEUCINE 360MG; SERINE 300MG

Antoreitti:

INTRAVENOUS

Kpl paketissa:

100

Prescription tyyppi:

Ethical

Terapeuttinen alue:

CALORIC AGENTS

Tuoteyhteenveto:

Active ingredient group (AIG) number: 1662220001; AHFS:

Valtuutuksen tilan:

APPROVED

Valtuutus päivämäärä:

2020-04-29

Valmisteyhteenveto

_Product Monograph Master Template _
_Template Date: September 2020 _
_CLINIMIX (Blend C & D) _
_Page 1 of 31_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
CLINIMIX
Amino Acids without Electrolytes in Dextrose Injection
5% Amino Acids (Blend C) without Electrolytes in 10% Dextrose
Injection
5% Amino Acids (Blend C) without Electrolytes in 16.6% Dextrose
Injection
6% Amino Acids (Blend D) without Electrolytes in 5% Dextrose Injection
8% Amino Acids (Blend D) without Electrolytes in 10% Dextrose
Injection
8% Amino Acids (Blend D) without Electrolytes in 14% Dextrose
Injection
Solution for Infusion, Intravenous
Intravenous Nutritive Supplements
Baxter Corporation
Mississauga, Ontario
L5N 0C2
Date of Initial Authorization:
DEC 31, 1993
Date of Revision:
MAR 31, 2022
Submission Control Number: 257427
Baxter, Clinimix, Clarity and Travasol are registered trademarks of
Baxter International Inc.
_ _
_Product Monograph Master Template _
_Template Date: September 2020 _
_CLINIMIX (Blend C & D) _
_Page 2 of 31_
RECENT MAJOR LABEL CHANGES
6 Warnings and Precautions
04/2020
3 Dosage and Administration
08/2020
6 Warnings and Precautions
08/2020
TABLE OF CONTENTS
SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF
AUTHORIZATION ARE NOT LISTED.
RECENT MAJOR LABEL
CHANGES............................................................................................
2
TABLE OF CONTENTS
..............................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION
.....................................................................
4
1
INDICATIONS
..............................................................................................................
4
1.1
Pediatrics
..........................................................................................................
4
1.2
Geriatrics...........................................................................................................
4
2
CONTRAINDICATIONS
...............